Kintara Therapeutics Inc KTRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
0.10quote price arrow down-0.00 (-2.78%)
Volume
82,483
Close
0.108quote price arrow down-0.0059 (-5.18%)
Volume
1,005,166
52 week range
0.10 - 1.10
Loading...
  • Open0.112
  • Day High0.1139
  • Day Low0.107
  • Prev Close0.1139
  • 52 Week High1.10
  • 52 Week High Date10/19/21
  • 52 Week Low0.10
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap8.73M
  • Shares Out80.81M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-78.82

KEY STATS

  • Open0.112
  • Day High0.1139
  • Day Low0.107
  • Prev Close0.1139
  • 52 Week High1.10
  • 52 Week High Date10/19/21
  • 52 Week Low0.10
  • 52 Week Low Date09/27/22
  • Market Cap8.73M
  • Shares Out80.81M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-78.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.56
  • P/E (TTM)-0.19
  • Fwd P/E (NTM)-3.60
  • EBITDA (TTM)-22.622M
  • ROE (TTM)-1,888.87%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/14/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kintara Therapeutics Inc

 

Profile

MORE
Kintara Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. The Company is developing and commercializing anti-cancer therapies for patients whose solid tumors exhibit features that make them resistant to, or unlikely to respond to available therapies, with particular focus on orphan cancer indications. The Company’s two lead candidates include VAL-083 and REM-001. Its VAL-083 is a novel...
Robert Hoffman CPA
Chairman of the Board, President, Chief Executive Officer
Scott Praill CPA
Chief Financial Officer
Address
9920 Pacific Heights Blvd
Suite 150, Suite 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
BTI
British American Tobacco PLC
35.50-0.48-1.33%
CWBR
CohBar Inc
2.88-0.09-3.03%
APLI
LMNL
Liminal BioSciences Inc
0.42UNCHUNCH
EDSA
Edesa Biotech Inc
0.9213-0.4987-35.1197%